|
Form 4 Filings | Insider Buys | Significant Buys |
Penny Stocks Insider Buying |
Insider Sales |
| Insider Buy Sell Ratios | Stock Options |
Insider Trading Top Lists |
Insider Trading Graph View |
Insider Watch |
|
|
"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise" - Peter Lynch ==>> What is insider trading>> |

| Transaction & Date | Reported Date |
Company | Symbol | Insider Relationship |
Shares Traded | Average Price | Total Amount |
Shares Ownership |
Filing |
| 2006-07-10 Purchase |
2006-07-10 3:31 pm | MANHATTAN PHARMACEUTICALS INC | MHA | ABEL DOUGLAS (President and CEO Director) | 5,000 | $0.75 | $3,750 | 30,000 (Direct) | View |
| 2005-11-18 Purchase |
2005-11-21 12:46 pm | MANHATTAN PHARMACEUTICALS INC | MHA | ABEL DOUGLAS (President and CEO Director) | 5,000 | $1.28 | $6,400 | 25,000 (Direct) |
View |
| 2005-10-21 Purchase |
2005-10-24 1:58 pm |
MANHATTAN PHARMACEUTICALS INC | MHTT | ABEL DOUGLAS (President and CEO Director) | 5,000 | $1.31 | $6,550 | 20,000 (Direct) |
View |
| 2005-10-20 Purchase |
2005-10-21 1:44 pm | MANHATTAN PHARMACEUTICALS INC | MHTT | ABEL DOUGLAS (President and CEO Director) | 5,000 | $1.293 | $6,466 | 15,000 (Direct) |
View |
| 2005-04-26 Purchase | 2005-04-28 1:47 pm |
MANHATTAN PHARMACEUTICALS INC | MHTT | ABEL DOUGLAS (President and CEO Director) | 2,500 | $1.42 | $3,550 | 10,000 (Direct) | View |
| 2005-04-22- -2005-04-25 Purchase | 2005-04-26 11:35 am | MANHATTAN PHARMACEUTICALS INC | MHTT | ABEL DOUGLAS (President and CEO Director) | 5,000 | $1.5 | $7,500 | 7,500 (Direct) |
View |
| 2005-04-21 Purchase |
2005-04-25 4:53 pm | MANHATTAN PHARMACEUTICALS INC | MHTT | ABEL DOUGLAS (President and CEO Director) | 2,500 | $1.53 | $3,825 | 2,500 (Direct) | View |
| Transaction & Date | Reported Date | Company | Symbol | Insider Relationship |
Shares Traded |
Average Price | Total Amount |
Shares Ownership | Filing |
| 2007-08-01 Option Award | 2007-08-02 12:17 pm | MANHATTAN PHARMACEUTICALS INC | MHA | ABEL DOUGLAS (Chief Executive Officer Director) | 10,000 | $0.265 | $2,650 | 45,000 (Indirect) |
View |
| 2007-07-20 Option Award | 2007-07-20 5:24 pm | MANHATTAN PHARMACEUTICALS INC | MHA | ABEL DOUGLAS (President and CEO Director) | 10,000 | $0.36 | $3,600 | 45,000 (Direct) |
View |
| 2007-07-13 Option Award | 2007-07-16 5:58 pm | MANHATTAN PHARMACEUTICALS INC | MHA | ABEL DOUGLAS (President and CEO Director) | 5,000 | $0.34 | $1,700 | 35,000 (Indirect) |
View |
| Transaction & Date |
Reported Date |
Exercisable Expiration |
Company | Symbol | Insider Relationship |
Shares Traded |
Conversion Price | Shares Ownership |
Filing |
| 2008-09-11 Option Award |
2008-09-15 6:28 pm |
N/A 2013-09-10 | MANHATTAN PHARMACEUTICALS INC | MHAN | ABEL DOUGLAS (President and CEO Director) | 24,000 | $0.2 | 24,000 (Direct) |
View |
| 2008-05-29 Option Award | 2008-06-02 12:58 pm | N/A 2018-05-28 | ARTES MEDICAL INC | ARTE | ABEL DOUGLAS (Director) | 12,500 | $0.97 | 12,500 (Direct) |
View |
| 2008-05-29 Option Award |
2008-06-02 12:58 pm | N/A N/A |
ARTES MEDICAL INC | ARTE | ABEL DOUGLAS (Director) | 6,250 | $0 | 6,250 (Direct) | View |
| 2008-03-25 Option Award |
2008-03-28 07:52 am | N/A 2018-03-25 |
MANHATTAN PHARMACEUTICALS INC | MHAN | ABEL DOUGLAS (President and CEO Director) | 1,300,000 | $0.17 | 1,300,000 (Direct) | View |
| 2007-04-25 Option Award | 2007-04-27 09:01 am |
N/A 2017-04-25 |
MANHATTAN PHARMACEUTICALS INC | MHA | ABEL DOUGLAS (President and CEO Director) | 250,000 | $0.95 | 250,000 (Direct) | View |
| 2005-04-01 Option Award |
2005-04-26 11:35 am | N/A 2015-04-01 |
MANHATTAN PHARMACEUTICALS INC | MHTT | ABEL DOUGLAS (President and CEO Director) | 2,923,900 | $1.5 | 2,923,900 (Direct) |
View |
| 2005-04-01 Option Award |
2005-04-25 4:53 pm |
N/A 2015-04-01 |
MANHATTAN PHARMACEUTICALS INC | MHTT | ABEL DOUGLAS (President and CEO Director) | 2,923,900 | $1.5 | 2,923,900 (Direct) | View |
|
© 2005-2008 SecForm4.Com All rights reserved. Archives: 2008 2007 2006 2005 2004 2003 Fri, 05 Dec 2008 04:50:33 -0600 |
SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC. SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC). Terms of Use | Privacy Statement | |